| Year |
Citation |
Score |
| 2022 |
Buhl E, Kim YA, Parsons T, Zhu B, Santa-Maria I, Lefort R, Hodge JJL. Effects of Eph/ephrin signalling and human Alzheimer's disease-associated EphA1 on Drosophila behaviour and neurophysiology. Neurobiology of Disease. 105752. PMID 35569721 DOI: 10.1016/j.nbd.2022.105752 |
0.398 |
|
| 2020 |
Mashkaryan V, Siddiqui T, Popova S, Cosacak MI, Bhattarai P, Brandt K, Govindarajan N, Petzold A, Reinhardt S, Dahl A, Lefort R, Kizil C. Type 1 Interleukin-4 Signaling Obliterates Mouse Astroglia but Not . Frontiers in Cell and Developmental Biology. 8: 114. PMID 32181251 DOI: 10.3389/Fcell.2020.00114 |
0.611 |
|
| 2019 |
Olabarria M, Pasini S, Corona C, Robador P, Song C, Patel H, Lefort R. Dysfunction of the ubiquitin ligase E3A Ube3A/E6-AP contributes to synaptic pathology in Alzheimer's disease. Communications Biology. 2: 111. PMID 31924939 DOI: 10.1038/s42003-019-0350-5 |
0.431 |
|
| 2019 |
Olabarria M, Pasini S, Corona C, Robador P, Song C, Patel H, Lefort R. Dysfunction of the ubiquitin ligase E3A Ube3A/E6-AP contributes to synaptic pathology in Alzheimer's disease. Communications Biology. 2: 111. PMID 30937395 DOI: 10.1038/s42003-019-0350-5 |
0.431 |
|
| 2017 |
Vardarajan BN, Tosto G, Lefort R, Yu L, Bennett DA, De Jager PL, Barral S, Reyes-Dumeyer D, Nagy PL, Lee JH, Cheng R, Medrano M, Lantigua R, Rogaeva E, St George-Hyslop P, et al. Ultra-rare mutations in SRCAP segregate in Caribbean Hispanic families with Alzheimer disease. Neurology. Genetics. 3: e178. PMID 28852706 DOI: 10.1212/Nxg.0000000000000178 |
0.337 |
|
| 2015 |
Aubry S, Shin W, Crary JF, Lefort R, Qureshi YH, Lefebvre C, Califano A, Shelanski ML. Assembly and interrogation of Alzheimer's disease genetic networks reveal novel regulators of progression. Plos One. 10: e0120352. PMID 25781952 DOI: 10.1371/Journal.Pone.0120352 |
0.646 |
|
| 2015 |
Shelanski M, Lefort R. Stuck in the mire. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 1-2. PMID 25608935 DOI: 10.1007/S13311-014-0333-7 |
0.649 |
|
| 2015 |
Lefort R. Reversing synapse loss in Alzheimer's disease: Rho-guanosine triphosphatases and insights from other brain disorders. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 19-28. PMID 25588580 DOI: 10.1007/S13311-014-0328-4 |
0.531 |
|
| 2015 |
Yang J, Lefort R, Sahin O. Nanomechanical Characterization of Active Synapses in Live Hippocampal Neurons Biophysical Journal. 108: 208a. DOI: 10.1016/J.Bpj.2014.11.1147 |
0.33 |
|
| 2014 |
Pianu B, Lefort R, Thuiliere L, Tabourier E, Bartolini F. The Aβ₁₋₄₂ peptide regulates microtubule stability independently of tau. Journal of Cell Science. 127: 1117-27. PMID 24424028 DOI: 10.1242/Jcs.143750 |
0.476 |
|
| 2013 |
Pozueta J, Lefort R, Ribe EM, Troy CM, Arancio O, Shelanski M. Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice. Nature Communications. 4: 1939. PMID 23748737 DOI: 10.1038/Ncomms2927 |
0.635 |
|
| 2013 |
Pozueta J, Lefort R, Shelanski ML. Synaptic changes in Alzheimer's disease and its models. Neuroscience. 251: 51-65. PMID 22687952 DOI: 10.1016/J.Neuroscience.2012.05.050 |
0.659 |
|
| 2012 |
Lefort R, Pozueta J, Shelanski M. Cross-linking of cell surface amyloid precursor protein leads to increased β-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 10674-85. PMID 22855816 DOI: 10.1523/Jneurosci.6473-11.2012 |
0.634 |
|
| 2009 |
Vitolo O, Gong B, Cao Z, Ishii H, Jaracz S, Nakanishi K, Arancio O, Dzyuba SV, Lefort R, Shelanski M. Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide J. Neurobiology of Aging. 30: 257-65. PMID 17640772 DOI: 10.1016/J.Neurobiolaging.2007.05.025 |
0.573 |
|
| Show low-probability matches. |